Clinical Trials Directory

Trials / Unknown

UnknownNCT02080104

Intramuscular Versus Intravenous Prophylactic Oxytocin for Hemorrhage After Vaginal Delivery

Intramuscular Versus Intravenous Prophylactic Oxytocin for the Third Stage of Labour Following Vaginal Delivery: A Randomised Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
2 (estimated)
Sponsor
Hediye Dagdeviren · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour following vaginal delivery: A randomised controlled trial

Detailed description

Prevention of postpartum haemorrhage is essential in the pursuit of improved health care for women. In this study investigators aimed to compare intramuscular oxytocin with intravenous oxytocin for the routine prevention of postpartum haemorrhage in women who deliver vaginally.In some countries, intravenous access can not be provided easily . Intramuscular application is faster , easier and tougher enforcement requires less skill and equipment . For this reason, less educated , which can be applied by those offering health services .

Conditions

Interventions

TypeNameDescription
DRUGintarvenous and intramusculer 10 IU oxytocinintarvenous and intramusculer 10 IU oxytocin

Timeline

Start date
2014-02-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2014-03-06
Last updated
2014-03-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02080104. Inclusion in this directory is not an endorsement.